Terms: = Lung cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Staging
5 results:
1. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
2. Mantle cell lymphoma presenting as bilateral adrenal huge masses.
Doroudinia A; Bakhshayesh Karam M; Ranjbar M; Nikmanesh A; Mehrian P
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29666081
[TBL] [Abstract] [Full Text] [Related]
3. The downregulation of mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
[TBL] [Abstract] [Full Text] [Related]
4. [Evaluation of sialyl SSEA-1 antigen in patients with lung cancer].
Shiota T; Matsubara Y; Ikeda S; Ishida H; Katsura A; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1067-73. PubMed ID: 2570808
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic features and prognosis for Wilms' tumor patients with metastases at diagnosis.
Breslow NE; Churchill G; Nesmith B; Thomas PR; Beckwith JB; Othersen HB; D'Angio GJ
Cancer; 1986 Dec; 58(11):2501-11. PubMed ID: 3021319
[TBL] [Abstract] [Full Text] [Related]